Log In
BCIQ
Print this Print this
 

Palomid 529 (RES-529) (formerly P529)

  Manage Alerts
Collapse Summary General Information
Company Diffusion Pharmaceuticals Inc.
DescriptionDual, synthetic, non-steroidal inhibitor of TORC1 and TORC2 complexes
Molecular Target CREB regulated transcription coactivator 1 (CRTC1) (TORC1) ; CREB regulated transcription coactivator 2 (CRTC2) (TORC2)
Mechanism of ActionCREB regulated transcription coactivator inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$12.5M

$12.5M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/17/2014

$12.5M

$12.5M

0

Get a free BioCentury trial today